New developments in HIV drug resistance. Cane Patricia A. Journal of Antimicrobial Chemotherapy . 2009Cane PA (2009) New developments in HIV drug resis- tance. J Antimicrob Chemother 64(Suppl 1), i37-i40.Cane PA. New developments in HIV drug resistance. J Antimicrob Chemother. 2009;64(...
[Hovanessian HC: New developments in the treatment of HIV disease: An overview. Ann Emerg Med May 1999;33:546-555.]HooriCHovanessianSDOSAnnals of Emergency MedicineHovanessian HC: New developments in the treatment of HIV disease: an overview. Ann Emerg Med 33(5): 546, 1999. [Pub...
Chapter 2 conducts the reader through the interconnected historical developments of the honeymoon as the "entry into heterosexual culture" and of Niagara Falls as a resort in the nineteenth and early twentieth centuries. Initially, she ... MK Davis - 《Journal of the History of Sexuality》 被引...
Describe and evaluate an implementation science network focused on HIV prevention and treatment in New England. In 2014, we established a partnership among university researchers and community stakeholders to stimulate and support HIV-related implementat
"Is there anything new in sex therapy?" Has the field of sex therapy been stagnating and failing to develop new treatments? Clearly, the important pharmaceutical advances of the past 11 years have overshadowed the developments in the field of sex therapy. Aim. The goal of this manuscript is ...
The 224 (56%) non-olfactory GPCRs that are yet to be explored in clinical trials have broad untapped therapeutic potential, particularly in genetic and immune system disorders. Further trends in GPCR drug discovery can be analysed in an interactive resource in the GPCRdb database. ...
New developments in anti-HIV chemotherapy Virtually all the compounds that are currently used, or under advanced clinical trial, for the treatment of HIV infections, belong to one of the following ... ED Clercq - 《Current Medicinal Chemistry》 被引量: 1111发表: 2001年 Markers of inflammation,...
interventions: an integrase inhibitor,dolutegravir;maraviroc, which blocks HIV from interacting with the CCR5 receptor on T cells; and nicotinamide, which is a form of vitamin B3, which may have some activity in waking up the dormant virus that persists in the body when people are on treatment...
Effects of HIV infection on age and cause of death for persons with hemophilia A in the United States Because of changes in factor replacement therapy and in treatment of human immunodeficiency virus (HIV) infection, we examined death record data for person... TL Chorba,RC Holman,MJ Clarke,....
et al. Elevation of IgE in HIV-infected subjects: a marker of poor prognosis. J. Allergy Clin. Immunol. 89, 68–75 (1992). Article CAS PubMed Google Scholar Irani, A.M. et al. Deficiency of the tryptase-positive, chymase-negative mast cell type in gastrointestinal mucosa of patients ...